Clinical Trial Update: Tinzaparin in the Treatment of the Acute Pulmonary Embolism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tinzaparin for acute pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Innohep (tinzaparin)

Snippet

Sponsor: Complejo Hospitalario Xeral-Calde | Conditions: Acute Pulmonary Embolism | Phase 4 | Status: COMPLETED